Science Explorer Back to mapMap
Discussion
Researcher · Southern Research Institute · United States

Mark J. Suto

Mark J. Suto publishes mostly in Molecular Biology, Organic Chemistry and Oncology, on topics such as Chemical Synthesis and Analysis, Cancer therapeutics and mechanisms and Synthesis and Biological Evaluation.

ORCID 0000-0003-0876-1210 OpenAlex
World rank
#2,129,334
of 7,710,434 ranked researchers
Rank in United States
#641,658
of 1,627,098
Works
153
Citations
3.5k
Citations per work
23.2
h-index
32
i10-index 68Top 13% in Molecular Biology
Mark J. Suto

What does Mark J. Suto research?

Mark J. Suto's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Chemistry (16%), Medicine (12%).

Everything else: 56 works · 36.9% of their workLife Sciences: 53 works · 34.8% of their workBiochemistry, Genetics and Molecular Biology: 53 works · 34.8% of their workMolecular Biology: 40 works · 26.4% of their workCancer Research: 9 works · 5.9% of their workGenetics: 4 works · 2.5% of their workPhysical Sciences: 24 works · 16.0% of their workChemistry: 24 works · 16.0% of their workOrganic Chemistry: 24 works · 16.0% of their workHealth Sciences: 19 works · 12.3% of their workMedicine: 19 works · 12.3% of their workOncology: 14 works · 9.1% of their workPharmacology: 5 works · 3.2% of their workTHEIR WORKMark J. Suto153works
Life Sciences35%Physical Sciences16%Health Sciences12%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else5636.9%
    1. Biochemistry, Genetics and Molecular Biology5334.8%
    1. Chemistry2416.0%
    1. Medicine1912.3%
  1. 1Molecular Biology26% of their works
  2. 2Organic Chemistry16% of their works
  3. 3Oncology9% of their works
  4. 4Cancer Research6% of their works
  5. 5Pharmacology3% of their works
  6. 6Genetics2% of their works

Research topics

Which keywords describe Mark J. Suto's research?

The keywords of their largest research topics: Heterocyclic Compounds, Medicinal Chemistry, Cancer, Inflammation, Signaling, Drug Discovery, Peptide Synthesis and DNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Heterocyclic Compounds192 topics
  2. Medicinal Chemistry192 topics
  3. Cancer172 topics
  4. Inflammation172 topics
  5. Signaling152 topics
  6. Drug Discovery131 topic
  7. Peptide Synthesis131 topic
  8. DNA121 topic
  9. Topoisomerases121 topic
  10. Quinoxaline111 topic
  11. Synthesis111 topic
  12. Immunity91 topic
  13. NF-?B91 topic
  14. IL-681 topic
  15. STAT381 topic
  16. Tubulin Inhibitors81 topic
  17. Vascular Targeting Agents81 topic
  18. Estrogen61 topic
  19. Olefin Metathesis61 topic
  20. Receptor61 topic
  21. Ruthenium Catalysts61 topic

Where does Mark J. Suto work?

Mark J. Suto's main affiliation in the publication record is Southern Research Institute, United States.

How many publications and citations does Mark J. Suto have?

OpenAlex counts 153 works and 3,546 citations for Mark J. Suto, an h-index of 32, ranking #2,129,334 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark J. Suto. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.